Credit Suisse Starts Pfizer (PFE) at Outperform, 'Investment Case Complex but Rewarding'
Tweet Send to a Friend
(Updated - November 17, 2022 4:11 PM EST)
Credit Suisse analyst Trung Huynh initiates coverage on Pfizer (NYSE: PFE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Credit Suisse analyst Trung Huynh initiates coverage on Pfizer (NYSE: PFE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
